304 related articles for article (PubMed ID: 8550956)
1. Increased plasma concentrations of interleukin-6, soluble interleukin-6, soluble interleukin-2 and transferrin receptor in major depression.
Maes M; Meltzer HY; Bosmans E; Bergmans R; Vandoolaeghe E; Ranjan R; Desnyder R
J Affect Disord; 1995 Aug; 34(4):301-9. PubMed ID: 8550956
[TBL] [Abstract][Full Text] [Related]
2. Plasma-soluble interleukin-2 and transferrin receptor in schizophrenia and major depression.
Maes M; Meltzer HY; Buckley P; Bosmans E
Eur Arch Psychiatry Clin Neurosci; 1995; 244(6):325-9. PubMed ID: 7772617
[TBL] [Abstract][Full Text] [Related]
3. Interleukin-2 and interleukin-6 in schizophrenia and mania: effects of neuroleptics and mood stabilizers.
Maes M; Bosmans E; Calabrese J; Smith R; Meltzer HY
J Psychiatr Res; 1995; 29(2):141-52. PubMed ID: 7666381
[TBL] [Abstract][Full Text] [Related]
4. Psychoimmune investigation in obsessive-compulsive disorder: assays of plasma transferrin, IL-2 and IL-6 receptor, and IL-1 beta and IL-6 concentrations.
Maes M; Meltzer HY; Bosmans E
Neuropsychobiology; 1994; 30(2-3):57-60. PubMed ID: 7800164
[TBL] [Abstract][Full Text] [Related]
5. Effects of symptomatic severity on elevation of plasma soluble interleukin-2 receptor in bipolar mania.
Tsai SY; Yang YY; Kuo CJ; Chen CC; Leu SJ
J Affect Disord; 2001 May; 64(2-3):185-93. PubMed ID: 11313085
[TBL] [Abstract][Full Text] [Related]
6. Indicators of immune activation in major depression.
Sluzewska A; Rybakowski J; Bosmans E; Sobieska M; Berghmans R; Maes M; Wiktorowicz K
Psychiatry Res; 1996 Oct; 64(3):161-7. PubMed ID: 8944394
[TBL] [Abstract][Full Text] [Related]
7. Persistent inflammation and its relationship to leptin and insulin in phases of bipolar disorder from acute depression to full remission.
Tsai SY; Chung KH; Huang SH; Chen PH; Lee HC; Kuo CJ
Bipolar Disord; 2014 Dec; 16(8):800-8. PubMed ID: 25130211
[TBL] [Abstract][Full Text] [Related]
8. Lipid Peroxidation and Immune Biomarkers Are Associated with Major Depression and Its Phenotypes, Including Treatment-Resistant Depression and Melancholia.
Sowa-Kućma M; Styczeń K; Siwek M; Misztak P; Nowak RJ; Dudek D; Rybakowski JK; Nowak G; Maes M
Neurotox Res; 2018 Feb; 33(2):448-460. PubMed ID: 29103192
[TBL] [Abstract][Full Text] [Related]
9. Increased serum IL-6 and IL-1 receptor antagonist concentrations in major depression and treatment resistant depression.
Maes M; Bosmans E; De Jongh R; Kenis G; Vandoolaeghe E; Neels H
Cytokine; 1997 Nov; 9(11):853-8. PubMed ID: 9367546
[TBL] [Abstract][Full Text] [Related]
10. Soluble interleukin-2 receptor levels correlated with positive symptoms during quetiapine treatment in schizophrenia-spectrum disorders.
Igue R; Potvin S; Bah R; Stip E; Bouchard RH; Lipp O; Gendron A; Kouassi E
Prog Neuropsychopharmacol Biol Psychiatry; 2011 Aug; 35(7):1695-8. PubMed ID: 21627977
[TBL] [Abstract][Full Text] [Related]
11. Chai-hu-gui-zhi-gan-jiang-tang regulates plasma interleukin-6 and soluble interleukin-6 receptor concentrations and improves depressed mood in climacteric women with insomnia.
Ushiroyama T; Ikeda A; Sakuma K; Ueki M
Am J Chin Med; 2005; 33(5):703-11. PubMed ID: 16265982
[TBL] [Abstract][Full Text] [Related]
12. Plasma concentrations of interleukin-1beta, interleukin-6, soluble interleukin-2 receptor and tumor necrosis factor alpha of depressed patients in Japan.
Kagaya A; Kugaya A; Takebayashi M; Fukue-Saeki M; Saeki T; Yamawaki S; Uchitomi Y
Neuropsychobiology; 2001; 43(2):59-62. PubMed ID: 11174046
[TBL] [Abstract][Full Text] [Related]
13. Associations of Serum Cytokine Receptor Levels with Melancholia, Staging of Illness, Depressive and Manic Phases, and Severity of Depression in Bipolar Disorder.
Siwek M; Sowa-Kućma M; Styczeń K; Misztak P; Nowak RJ; Szewczyk B; Dudek D; Rybakowski JK; Nowak G; Maes M
Mol Neurobiol; 2017 Oct; 54(8):5883-5893. PubMed ID: 27660275
[TBL] [Abstract][Full Text] [Related]
14. Immunoendocrine aspects of major depression. Relationships between plasma interleukin-6 and soluble interleukin-2 receptor, prolactin and cortisol.
Maes M; Bosmans E; Meltzer HY
Eur Arch Psychiatry Clin Neurosci; 1995; 245(3):172-8. PubMed ID: 7669825
[TBL] [Abstract][Full Text] [Related]
15. Immune-inflammatory markers in schizophrenia: comparison to normal controls and effects of clozapine.
Maes M; Meltzer HY; Bosmans E
Acta Psychiatr Scand; 1994 May; 89(5):346-51. PubMed ID: 8067274
[TBL] [Abstract][Full Text] [Related]
16. Soluble interleukin-2 receptor and tumor necrosis factor levels in depressed patients in Estonia.
Eller T; Aluoja A; Maron E; Vasar V
Medicina (Kaunas); 2009; 45(12):971-7. PubMed ID: 20173400
[TBL] [Abstract][Full Text] [Related]
17. Are there differences in lipid peroxidation and immune biomarkers between major depression and bipolar disorder: Effects of melancholia, atypical depression, severity of illness, episode number, suicidal ideation and prior suicide attempts.
Sowa-Kućma M; Styczeń K; Siwek M; Misztak P; Nowak RJ; Dudek D; Rybakowski JK; Nowak G; Maes M
Prog Neuropsychopharmacol Biol Psychiatry; 2018 Feb; 81():372-383. PubMed ID: 28867391
[TBL] [Abstract][Full Text] [Related]
18. Plasma soluble interleukin-2-receptor in depression: relationships to plasma neopterin and serum IL-2 concentrations and HPA-axis activity.
Maes M; Bosmans E; Scharpé S; D'Hondt P; Desnyder R
Eur Psychiatry; 1995; 10(8):397-403. PubMed ID: 19698376
[TBL] [Abstract][Full Text] [Related]
19. Elevated serum interleukin-6 (IL-6) and IL-6 receptor concentrations in posttraumatic stress disorder following accidental man-made traumatic events.
Maes M; Lin AH; Delmeire L; Van Gastel A; Kenis G; De Jongh R; Bosmans E
Biol Psychiatry; 1999 Apr; 45(7):833-9. PubMed ID: 10202570
[TBL] [Abstract][Full Text] [Related]
20. [A study of cytokine expression in peripheral blood of patients with Graves' ophthalmopathy].
Tang L; Luo Q; Zhou X; Xia R
Zhonghua Yan Ke Za Zhi; 2002 Mar; 38(3):165-7. PubMed ID: 11955323
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
